Nymox Pharmaceutical Corporation (NYMXF)

Nymox Pharmaceutical Statistics

Total Valuation

NYMXF has a market cap or net worth of $91.72 million. The enterprise value is $91.48 million.

Market Cap	91.72M
Enterprise Value	91.48M

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.26%
Owned by Institutions (%)	1.21%
Float	50.86M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.19

Current Ratio	0.19
Quick Ratio	0.15
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-86.18

Financial Efficiency

Return on equity (ROE) is -1,589.50%.

Return on Equity (ROE)	-1,589.50%
Return on Assets (ROA)	-117.20%
Return on Capital (ROIC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.23% in the last 52 weeks. The beta is 1.19, so NYMXF's price volatility has been higher than the market average.

Beta (1Y)	1.19
52-Week Price Change	-30.23%
50-Day Moving Average	0.39
200-Day Moving Average	0.62
Relative Strength Index (RSI)	40.01
Average Volume (30 Days)	n/a

Short Selling Information

Short Interest	2.03M
Short Previous Month	2.08M
Short % of Shares Out	n/a
Short % of Float	4.00%
Short Ratio (days to cover)	59.74

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-2.96M
Pretax Income	-2.88M
Net Income	-2.88M
EBITDA	-2.60M
EBIT	-2.84M
Earnings Per Share (EPS)	-$0.04

Balance Sheet

The company has $351,000 in cash and $114,000 in debt, giving a net cash position of $237,000.

Cash & Cash Equivalents	351,000
Total Debt	114,000
Net Cash	237,000
Net Cash Per Share	n/a
Equity / Book Value	-1.80M
Book Value Per Share	n/a
Working Capital	-1.91M

Cash Flow

In the last 12 months, operating cash flow was -$1.99 million and capital expenditures -$3,000, giving a free cash flow of -$1.99 million.

Operating Cash Flow	-1.99M
Capital Expenditures	-3,000
Free Cash Flow	-1.99M
FCF Per Share	-$0.02

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NYMXF does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5.22%
Shareholder Yield	-5.22%
Earnings Yield	-3.14%
FCF Yield	-2.17%

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1